Simplex Trading’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113K Buy
10,151
+9,261
+1,041% +$113K ﹤0.01% 5395
2026
Q1
$12.4K Sell
890
-908
-51% -$12.7K ﹤0.01% 7159
2025
Q4
$25.9K Sell
1,798
-2,776
-61% -$41.8K ﹤0.01% 6240
2025
Q3
$72K Buy
4,574
+3,676
+409% +$60.6K ﹤0.01% 6090
2025
Q2
$15K Buy
+898
New +$17.5K ﹤0.01% 6990
2024
Q1
Sell
-78
Closed -$1K 8867
2023
Q4
$1K Buy
+78
New +$1.55K ﹤0.01% 8437

Other funds holding BTAL

Simplex Trading's BTAL Position: Q2 2026 in Review

Simplex Trading increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 1,041% in Q2 2026, buying an estimated $113K and bringing the position to 10,151 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #5395.

Simplex Trading first reported a position in BTAL in Q4 2023 and has held it in 6 quarters since. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Simplex Trading held 10,151 shares of AGF US Market Neutral Anti-Beta Fund worth $113K as of Q2 2026.
  • Simplex Trading bought 9,261 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $113K.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5395 holding.
  • Simplex Trading first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2023 and has held it in 6 quarters since.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.